We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.8B
AUM Growth
+$2.95B
Cap. Flow
+$1.1B
Cap. Flow %
4.63%
Top 10 Hldgs %
44.66%
Holding
165
New
18
Increased
38
Reduced
31
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 32.61%
2 Technology 13.02%
3 Financials 8.98%
4 Communication Services 7.2%
5 Industrials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBNX
51
Beta Bionics
BBNX
$715M
$61.2M 0.26%
4,203,920
+871,700
+26% +$12.3M
CNTA
52
DELISTED
Centessa Pharmaceuticals
CNTA
$59.5M 0.25%
4,529,318
+195,000
+4% +$2.47M
AMED
53
DELISTED
Amedisys
AMED
$56.6M 0.24%
575,000
+50,000
+10% +$4.73M
LQDA icon
54
Liquidia Corp
LQDA
$8.02B
$52.8M 0.22%
4,238,762
+247,806
+6% +$3.67M
FLUT icon
55
Flutter Entertainment
FLUT
$16.4B
$51.8M 0.22%
181,229
-60,238
-25% -$14.8M
TNGX icon
56
Tango Therapeutics
TNGX
$4.41B
$46.9M 0.2%
9,157,000
+4,546,070
+99% +$11.2M
SGRY icon
57
Surgery Partners
SGRY
$2.03B
$42.8M 0.18%
+1,926,000
New +$42.8M
VERV
58
DELISTED
Verve Therapeutics
VERV
$40.6M 0.17%
3,612,000
+2,700,000
+296% +$15.4M
JOYY
59
JOYY Inc
JOYY
$3.75B
$40.1M 0.17%
787,906
+7,906
+1% +$351K
HQY icon
60
HealthEquity
HQY
$8.75B
$33.5M 0.14%
319,800
-102,000
-24% -$9.67M
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$2.55B
$32.7M 0.14%
+898,000
New +$32.4M
OSCR icon
62
Oscar Health
OSCR
$8.61B
$31.6M 0.13%
1,476,000
+1,465,000
+13,318% +$21.8M
WGS icon
63
GeneDx Holdings
WGS
$2.3B
$30.2M 0.13%
326,677
+23,677
+8% +$1.86M
GRAL
64
GRAIL Inc
GRAL
$3.1B
$25.8M 0.11%
+502,000
New +$18.2M
WAY
65
Waystar Holding Corp
WAY
$4.65B
$25.1M 0.11%
613,000
-1,407,000
-70% -$54.2M
SDGR icon
66
Schrodinger
SDGR
$1.36B
$22.3M 0.09%
+1,106,000
New +$25.3M
VNET
67
VNET Group
VNET
$2.09B
$20.7M 0.09%
2,994,120
+555,000
+23% +$3.32M
ALKS icon
68
Alkermes
ALKS
$8.25B
$19.8M 0.08%
691,663
-698,137
-50% -$20.8M
ABT icon
69
Abbott
ABT
$187B
$18.5M 0.08%
136,000
-197,000
-59% -$26M
YMM icon
70
Full Truck Alliance
YMM
$9.99B
$18.3M 0.08%
1,550,598
-5,806,609
-79% -$67.6M
COOP
71
DELISTED
Mr. Cooper
COOP
$18.3M 0.08%
+122,500
New +$15.7M
PARA
72
DELISTED
Paramount Global Class B
PARA
$17.4M 0.07%
+1,346,151
New +$15.8M
TECX
73
Tectonic Therapeutic
TECX
$606M
$17M 0.07%
853,050
ENTA icon
74
Enanta Pharmaceuticals
ENTA
$400M
$16M 0.07%
2,122,262
SVRA icon
75
Savara
SVRA
$1.19B
$15.6M 0.07%
6,835,000

Similar funds

Farallon Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Farallon Capital Management held 165 positions worth $23.8B, up 14% from $20.9B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Farallon Capital Management deployed $1.1B of net new capital in Q2 2025, opening 18 new positions and adding to 38 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 5,500,000 shares worth $3.4B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 38% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Exelixis, an estimated $260M trimmed.

  • Farallon Capital Management's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 5,500,000 shares worth $3.4B.
  • Farallon Capital Management added most to Aon in Q2 2025, an estimated $226M increase.
  • Farallon Capital Management's biggest Q2 2025 reduction was Exelixis, cutting an estimated $260M.
  • Farallon Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $816M.
  • Farallon Capital Management's ten largest holdings make up 45% of its $23.8B portfolio in Q2 2025.
  • Farallon Capital Management opened 18 new positions and closed 20 in Q2 2025.
  • Farallon Capital Management's portfolio value rose 14% quarter-over-quarter to $23.8B.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.